For the continuum of mental health we need a whole system, h...
If we don’t address the mental health of young people, that mental health challenge will advance into the adult population of tomorrow.
Revolutionising personalised medicine: How IRT platforms are...
Cell and gene therapies offers transformative benefits to patients, including revolutionary treatment potential for cancer, AIDS, and hereditary diseases.
New Boehringer US Head Brian Hilberdink talks GLP-1s, DTx an...
At Reuters Pharma USA, editor-in-chief Jonah Comstock caught up with Brian Hilberdink, the new head of US human pharma at Boehringer Ingelheim.
Alphabet's Isomorphic raises $600m for AI drug discovery
Isomorphic Labs has raised a whopping $600 million to refine its artificial intelligence-powered drug discovery engine and advance its pipeline.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
The Home of Accelerating Microbiome R&D
10th Annual Microbiome Movement returns with many new & exciting features including...
Accelerating Breakthroughs in Immunodermatology Drug Develop...
Your Collaborative Forum to Shape the Future of Dermatology
Structure-Based Drug Design Summit Returns This June
With tightening budgets and increasing pressure to de-risk R&D, pharma and biotech are shifting their focus toward smarter, more efficient drug design.
Returning for a 4th Year... GPCRs-Targeted Drug Discovery!
Transforming the Discovery of Novel GPCR-Targeted Therapies
LEAP HR: Life Sciences East
Save the Date for LEAP HR: Life Sciences East!